A healthcare professional is preparing to administer Butorphanol to a client who has a history of substance use disorder. The healthcare professional should identify which of the following information as true regarding Butorphanol?

Questions 121

ATI RN

ATI RN Test Bank

ATI Pharmacology Questions

Question 1 of 9

A healthcare professional is preparing to administer Butorphanol to a client who has a history of substance use disorder. The healthcare professional should identify which of the following information as true regarding Butorphanol?

Correct Answer: D

Rationale: Butorphanol is an opioid agonist/antagonist that can precipitate withdrawal symptoms in opioid-dependent individuals. Symptoms of abstinence syndrome can include abdominal pain, fever, and anxiety. This occurs because butorphanol competes with and displaces opioid agonists from receptors, leading to withdrawal symptoms in opioid-dependent clients.

Question 2 of 9

A healthcare professional is preparing to administer clindamycin 200 mg by intermittent IV bolus. The amount available is clindamycin injection 200 mg in 100 mL 0.9% sodium chloride (0.9% NaCl) to infuse over 30 min. The healthcare professional should set the IV pump to deliver how many mL/hr?

Correct Answer: A

Rationale: To calculate the flow rate in mL/hr: (Volume in mL / Time in hours) = Flow rate in mL/hr. In this case, (100 mL / 0.5 hr) = 200 mL/hr. The correct calculation is: 100 mL (volume) / 0.5 hr (time) = 200 mL/hr.

Question 3 of 9

A client is receiving epoetin alfa to treat anemia. Which of the following findings should the nurse monitor?

Correct Answer: B

Rationale: The nurse should monitor the client for hypertension when receiving epoetin alfa as it is a common adverse effect caused by increased red blood cell production. Epoetin alfa stimulates red blood cell production, which can lead to increased blood pressure. Monitoring blood pressure is crucial to detect and manage hypertension promptly.

Question 4 of 9

A client has a new prescription for a Nitroglycerin transdermal patch. Which of the following instructions should the nurse include?

Correct Answer: B

Rationale: The correct instruction for a Nitroglycerin transdermal patch is to remove it each day, usually at bedtime, to prevent tolerance. The client should apply a new patch the next morning to maintain its therapeutic effect.

Question 5 of 9

A nurse is teaching a female client who has tobacco use disorder about Nicotine replacement therapy. Which of the following statements by the client indicates understanding of the teaching?

Correct Answer: A

Rationale: The client should avoid eating or drinking 15 min prior to and while chewing the nicotine gum.

Question 6 of 9

A client with tobacco use disorder is being educated about Nicotine replacement therapy. Which statement by the client indicates an understanding of the teaching?

Correct Answer: A

Rationale: To maximize the effectiveness of nicotine gum, the client should avoid eating or drinking 15 minutes before and while using it. This helps ensure proper absorption of nicotine through the oral mucosa.

Question 7 of 9

A client in an outpatient facility is taking Acarbose for type 2 Diabetes Mellitus. Which of the following laboratory tests should the nurse plan to monitor?

Correct Answer: D

Rationale: Acarbose, used for type 2 Diabetes Mellitus, can lead to liver toxicity with long-term use. Therefore, monitoring liver function tests periodically is essential to detect any signs of liver dysfunction early and prevent complications.

Question 8 of 9

When teaching a client about a new prescription for Celecoxib, which of the following information should the nurse include?

Correct Answer: A

Rationale: The nurse should educate the client that taking Celecoxib increases the risk of a myocardial infarction due to its suppression of vasodilation. This medication belongs to the class of NSAIDs known to have cardiovascular risks, including an increased risk of heart attacks. Therefore, it is essential for the nurse to emphasize this potential adverse effect during client teaching to ensure the client is aware of the associated risks.

Question 9 of 9

When caring for a client receiving treatment with irinotecan, which of the following findings should the nurse monitor?

Correct Answer: A

Rationale: The correct answer is diarrhea. Irinotecan commonly causes diarrhea as an adverse effect due to its impact on the gastrointestinal tract. Monitoring for diarrhea is essential to prevent dehydration and manage this side effect effectively.

Access More Questions!

ATI RN Basic


$89/ 30 days

ATI RN Premium


$150/ 90 days